Invesco
PRCT icon

Invesco’s Procept Biorobotics PRCT Stock Holding History

Invesco’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Buy
55,146
+791
+1% +$19.8K ﹤0.01% 2814
2026
Q1 		$1.36M Buy
54,355
+10,785
+25% +$304K ﹤0.01% 2729
2025
Q4 		$1.37M Buy
43,570
+7,191
+20% +$238K ﹤0.01% 2771
2025
Q3 		$1.3M Sell
36,379
-374,475
-91% -$17.1M ﹤0.01% 2812
2025
Q2 		$23.7M Sell
410,854
-9,973
-2% -$564K ﹤0.01% 1342
2025
Q1 		$24.5M Sell
420,827
-79,122
-16% -$5.4M ﹤0.01% 1337
2024
Q4 		$40.3M Buy
499,949
+231,470
+86% +$19.8M 0.01% 1145
2024
Q3 		$21.5M Buy
268,479
+216,999
+422% +$15.4M ﹤0.01% 1437
2024
Q2 		$3.14M Buy
51,480
+32,960
+178% +$1.96M ﹤0.01% 2398
2024
Q1 		$915K Sell
18,520
-2,491
-12% -$119K ﹤0.01% 3033
2023
Q4 		$881K Buy
21,011
+7,057
+51% +$240K ﹤0.01% 2949
2023
Q3 		$458K Buy
13,954
+5
+0% +$170 ﹤0.01% 3242
2023
Q2 		$493K Buy
13,949
+3,031
+28% +$100K ﹤0.01% 3248
2023
Q1 		$310K Sell
10,918
-35,413
-76% -$1.25M ﹤0.01% 3489
2022
Q4 		$1.92M Sell
46,331
-79,538
-63% -$3.42M ﹤0.01% 2665
2022
Q3 		$5.22M Buy
125,869
+81,964
+187% +$3.27M ﹤0.01% 2208
2022
Q2 		$1.44M Buy
+43,905
New +$1.6M ﹤0.01% 2848

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco's PRCT Position: Q2 2026 in Review

Invesco increased its Procept Biorobotics (PRCT) stake by 1.5% in Q2 2026, buying an estimated $19.8K and bringing the position to 55,146 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2814.

Invesco first reported a position in PRCT in Q2 2022 and has held it in 17 quarters since. The position peaked at $40.3M in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Invesco held 55,146 shares of Procept Biorobotics worth $1.25M as of Q2 2026.
  • Invesco bought 791 Procept Biorobotics shares in Q2 2026, an estimated $19.8K.
  • Procept Biorobotics made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2814 holding.
  • Invesco first reported a position in Procept Biorobotics in Q2 2022 and has held it in 17 quarters since.
  • Invesco's Procept Biorobotics position peaked at $40.3M in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.